Total planned funding: $84,126,405
Allocations
Countries/Regions
Ukraine | $84,126,405 |
Organizational Types
Unknown | $21,543,032 |
Private Contractor | $18,793,782 |
NGO | $12,307,356 |
Multi-lateral Agency | $10,689,021 |
Own Agency | $8,690,408 |
Other USG Agency | $5,142,806 |
University | $4,260,000 |
Implementing Agency | $2,700,000 |
Program Areas
Governance and Systems | $37,974,608 |
Treatment | $12,530,442 |
Prevention | $11,652,591 |
Testing | $8,536,453 |
Care | $7,979,663 |
Management and Operations | $5,452,648 |
Budget Codes
OHSS: Health Systems Strengthening | $17,588,372 |
HVSI: Strategic Information | $12,649,741 |
HTXS: Treatment: Adult Treatment | $9,925,152 |
HVCT: Testing: HIV Testing and Counseling | $8,536,453 |
HLAB: Laboratory Infrastructure | $7,736,495 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,730,846 |
HVMS: Management and Operations | $5,452,648 |
HVTB: Care: TB/HIV | $4,616,643 |
HVOP: Sexual Prevention: Other Sexual Prevention | $3,038,562 |
HTXD: Treatment: ARV Drugs | $2,605,290 |
HMBL: Biomedical Prevention: Blood Safety | $2,457,426 |
HBHC: Care: Adult Care and Support | $1,754,448 |
HKID: Care: Orphans and Vulnerable Children | $1,608,572 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $132,400 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$21,543,032
Countries/Regions
Deloitte Consulting Limited:
$10,625,011
Countries/Regions
USG Aggregated Agencies:
$7,875,408
Countries/Regions
Chemonics International:
$7,168,771
Countries/Regions